Investorideas.com breaking new for AI and tech stocks

Friday, December 6, 2024

November Wrap-up; New Stocks to Watch in Biotech, Mining and Tech; (Nasdaq: $CERO) (CSE: $HEAL.CN) (Nasdaq: $GELS) (CSE: $DMC.CN) (CSE: $MERC.CN) (CSE: $ARMY.CN) (NASDAQ: $ARBE) (NYSE: $GNS)

 November Wrap-up; New Stocks to Watch in Biotech, Mining and Tech; (Nasdaq: $CERO) (CSE: $HEAL.CN) (Nasdaq: $GELS) (CSE: $DMC.CN) (CSE: $MERC.CN) (CSE: $ARMY.CN) (NASDAQ: $ARBE) (NYSE: $GNS)

 



 

 

December 6, 2024 – (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces today’s roundup of stocks to watch in the biotech, mining and tech sectors.

 

The newest biotech companies are involved in cancer treatment, neuroinflammatory disorders and nutrient and drug delivery, respectively.

 

The latest mining companies are all CSE (Canadian Stock Exchange) listed.

 

The newest tech companies are involved in safety for autonomous vehicles and AI.

 

New stocks added today: CERo Therapeutics Holdings, Inc. (Nasdaq: CERO), Restart Life Sciences Corp. (CSE:HEAL), Gelteq Limited (Nasdaq:GELS), Dunbar Metals Corp. (CSE: DMC), Mercado Minerals Ltd. (CSE:MERC), Armory Mining Corp. (CSE: ARMY), Arbe Robotics Ltd. (NASDAQ:ARBE), Genius Group (NYSE: GNS).

 

Read this in full at https://www.investorideas.com/news/2024/main/12061Stocks.asp

 

Investor Ideas is always researching and searching for new stocks to add to our growing list of free stock directories. The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

 

New Stocks Added to the Tech Directories:

Arbe Robotics Ltd. (NASDAQ:ARBE) a global leader in Perception Radar solutions, is spearheading a radar revolution, enabling safe driver-assist systems today while paving the way to full autonomous-driving. Arbe's radar technology is 100 times more detailed than any other radar on the market and is a critical sensor for L2+ and higher autonomy. The company is empowering automakers, Tier 1 suppliers, autonomous ground vehicles, commercial and industrial vehicles, and a wide array of safety applications with advanced sensing and paradigm changing perception. Arbe is based in Tel Aviv, Israel, and has offices in China, Germany, and the United States.

 

Genius Group (NYSE: GNS) is a leading provider of AI powered, digital-first education and acceleration solutions for the future of work. Genius Group serves 5.4 million users in over 100 countries through its Genius City model and online digital marketplace of AI training, AI tools and AI talent. It provides personalized, entrepreneurial AI pathways combining human talent with AI skills and AI solutions at the individual, enterprise and government level.

 

New Stocks Added to the Mining Directories:

Dunbar Metals Corp. (CSE: DMC) is engaged in the business of the acquisition and exploration of mineral properties in Canada. The Company holds a 100% interest in and to mineral claims totaling 6,949.80 hectares comprising the Gorilla Lake Property, located in North Saskatchewan, Canada, subject to a royalty obligation. The Company’s secondary objective is to locate and develop economic precious and base metals properties of merit.

 

Mercado Minerals Ltd. (CSE:MERC) Formerly Heartfield Mining Corp. –is a company involved in the business of acquiring and exploring mineral properties in Canada and the United States. Mercado has been primarily involved in the exploration and evaluation of the Porter Property, located within Alberni Mining Divisions of British Columbia.

 

Armory Mining Corp. (CSE: ARMY)- formerly Spey Resources Corp - is a junior mineral exploration company. Spey is engaged in the business of acquiring, exploring and evaluating natural resource properties. Spey has an option to acquire a 100% undivided interest in the Silver Basin Property (the “Property”) located in the Revelstoke Mining Division, of southern British Columbia.

 

New Stocks Added to the Biotech Directories:

CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) is an innovative immunotherapy company advancing the development of next generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body’s full immune repertoire to achieve optimized cancer therapy. This novel cellular immunotherapy platform is expected to redirect patient-derived T cells to eliminate tumors by building in engulfment pathways that employ phagocytic mechanisms to destroy cancer cells, creating what CERo refers to as Chimeric Engulfment Receptor T cells (“CER-T”). CERo believes the differentiated activity of CER-T cells will afford them greater therapeutic application than currently approved chimeric antigen receptor (“CAR-T”) cell therapy, as the use of CER-T may potentially span both hematological malignancies and solid tumors. CERo anticipates initiating clinical trials for its lead product candidate, CER-1236, in early 2025 for AML.

 

Restart Life Sciences Corp. (CSE:HEAL) Formerly Nova Mentis Life Science Corp - is a Canadian-based biotechnology company and global leader in psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders. Their mission is to diagnose and treat debilitating chronic conditions that have unmet medical needs, such as autism spectrum disorder and fragile X syndrome.

 

Gelteq Limited (Nasdaq:GELS) Headquartered in Melbourne, Australia, Gelteq is a global biotechnology company that specializes in the formulation, development, and manufacturing of an innovative ingestible gel platform designed for nutrient and drug delivery. The Company is focused on advancing and commercializing its delivery solutions within five core verticals: pharmaceuticals, over-the-counter medications, nutraceuticals, animal medications, and sports nutrition. Gelteq’s unique formulation directly addresses the issues associated with traditional drug delivery methods such as difficulty swallowing, taste of unpalatable ingredients, and dosage control.

 

About Investorideas.com - Big Investing Ideas

Investorideas.com is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all. Our original branded content includes podcasts such as Exploring Mining, Cleantech, Crypto Corner, Cannabis News, and the AI Eye. We also create free investor stock directories for various sectors, including gaming, biotech, tech and sports. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors. Paid content is always disclosed.

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

 

Learn more about advertising and guest posts

https://www.investorideas.com/Advertise/

 

Follow us on Twitter (X) https://X.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

 

Contact Investorideas.com to be added to our stock directories or learn more about us

Dawn Van Zant and Cali Van Zant

 

800 665 0411

 

 



 

 

 


No comments:

Post a Comment